| ID | 2037 |
|---|
| No | 2037 |
|---|
| Brand Name | CEFO - L 100 MG |
|---|
| Ingredients | CEFIXIME TRIHYDRATE USP 114.24 MG EQ.TO CEFIXIME ANHYDROUS 100 MG, LACTIC ACID BACILLUS 60 MILLION SPORES 35 MG |
|---|
| Dosage Form | TABLET |
|---|
| Primary Packaging | ALU-ALU BLISTERPACK |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 10 X 10'S |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | RESPIRATORY TRACT INFECTIONS, OTITIS MEDIA, SEQUENTIAL TREATMENT AFTER INITIAL I.V. CHEMOTHERAPY AFTER PARENTERAL CEPHALOSPORIN, URINARY TRACT INFECTIONS, GONORRHOEA, TYPHOID FEVER. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL | NULL |
|---|
| Description | YELLOW COLORED, CIRCULAR, FLAT BEVELED EDGED, UNCOATED TABLET HAVING PLAIN ON ONE SIDE & BREAK LINE ON OTHER SIDE |
|---|
| Note | |
|---|
| License Owner | PALAMY PHARMA CO., LTD |
|---|
| Manufacturer | MEDLEY PHARMACEUTICALS LTD. |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 07 I 3144/08 |
|---|
| FDD Registration Date | 02/02/2023 |
|---|
| Expiry Date | 01/02/2026 |
|---|
